This brand name is authorized in Ecuador
The drug TRI-K contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Potassium bicarbonate
UNII HM5Z15LEBN - POTASSIUM BICARBONATE
|
|
|
|
2
Potassium citrate
UNII EE90ONI6FF - POTASSIUM CITRATE
|
|
Citrate and citric acid solutions are systematic and urinary alkalinizers thereby providing symptomatic relief of dysuria. |
|
3
UNII M911911U02 - POTASSIUM ACETATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12BA51 | Potassium chloride, combinations | A Alimentary tract and metabolism → A12 Mineral supplements → A12B Potassium → A12BA Potassium |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 2.907-4-05-02 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
